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Abstract: Reporter viruses are useful probes for studying multiple stages of the viral life cycle.
Here we describe an expanded toolbox of fluorescent and bioluminescent influenza A reporter
viruses. The enhanced utility of these tools enabled kinetic studies of viral attachment, infection,
and co-infection. Multi-modal bioluminescence and positron emission tomography–computed
tomography (PET/CT) imaging of infected animals revealed that antiviral treatment reduced viral
load, dissemination, and inflammation. These new technologies and applications will dramatically
accelerate in vitro and in vivo influenza virus studies.
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1. Introduction
Influenza replication is a highly dynamic process. Yet, the majority of our knowledge about
the replication cycle is extrapolated from static snapshots during an infection. This limitation can be
overcome by using reporter viruses that facilitate real-time longitudinal measures of virus replication.
Existing influenza reporter viruses encoding luciferases or fluorescent proteins have proven useful in
rapidly measuring viral infection in vitro and most recently in animals [1–14]. However, some reporter
viruses fail to recapitulate wild-type infection due to attenuation, genetic instability, disrupted
splicing and altered gene expression [3–14]. There is thus a need for improved reporter viruses and
specialized applications that probe discrete stages of viral replication and pathogenesis.
Recently, we developed an influenza reporter virus expressing NanoLuc (NLuc) [15] that
possesses native-like replication properties and is suitable for in vivo imaging [1]. NLuc was encoded
on the polymerase subunit PA gene separated by a 2A sequence to generate a “self-cleaving”
polyprotein (Figure 1A). Silent mutations were introduced into the PA open reading frame (ORF)
and downstream packaging signals were restored to create a PA-Swap-2A-Nluc (PASTN) virus in the
strains A/WSN/33 (H1N1)(WSN) [1], the 2009 pandemic A/California/04/2009 (H1N1)(CA04) [2],
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A/Puerto Rico/8/1934 (H1N1), A/Vietnam/1203/2004 (H5N1), and A/Anhui/01/2013 (H7N9)
(data not shown). Both PASTN and PASTNCA04 replicated in culture and in vivo with kinetics, titers,
and pathogenicity remarkably similar to the parental viruses. PASTNCA04 was further used to track
contact- and aerosol-based transmission in real time, with transmission patterns and kinetics similar
to the parental strain. Thus, PASTN represents a powerful tool for quantitative, real-time, serial
measures of viral replication and dissemination in culture and in animal models.
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Figure  1.  Characterization  of  a  toolbox  of  influenza  PA‐reporter  viruses.  (A)  Schematic  of  
PA‐reporter gene fusions encoding PA polyproteins containing the 2A peptide (PA‐2A‐GFP [PATG] 
and PA‐2A‐RFP [PATR]) or PA direct fusions that lack the 2A sequence (PA‐SWAP‐NLuc [PASN]). 
Silent mutations  introduced  into  the  terminal 47 nt of  the PA  coding  sequence are depicted with 
diagonal  lines  and  the  50  nt  repeat  of  the  PA  open  reading  frame  (ORF)  that  maintains  the 
packaging signal is shown. (B–C) Multicycle replication kinetics of parental WSN and PA‐reporter 
viruses in A549 cells infected at a multiplicity of infection (MOI) = 0.01. Viral titers were determined 
at  the  indicated  time  points  by  plaque  assay. Data  are mean  of  n = 3  ±  standard deviation  (sd). 




The  influenza  reverse  genetics  system  pTM‐polI‐WSN‐All  was  a  kind  gift  from  Y. 
Kawaoka  [16].  pTMΔRNP was  derived  from  pTM‐polI‐WSN‐All [17].  The  virus  rescue  constructs 
pBD‐PB1,  ‐PB2,  ‐PA, and  ‐NP express both viral RNA  (vRNA) and messenger  (mRNA) and have 
been described previously [17, 18]. 
PA‐based  reporter genes were constructed  following our previous approach   [1]. Briefly,  the 
PA  open  reading  frame  (ORF)  was  fused  to  coding  sequence  for  Nluc,  mRFP  or  eGFP.  NLuc 
sequences were  amplified  from  pNL1.1  (Promega, Madison, WI, USA).  To  restore  the  required 
packaging signal, the 3′ 50 nt from the PA ORF were repeated after the reporter genes and followed 
by  the untranslated  region  from  the PA gene. Where  indicated,  the 3′ 50 nt  in  the PA ORF were 
codon  optimized  (i.e.,  “swapped”)  to  remove duplicate packaging  signals  and  sequence  repeats. 
Figure 1. Characterization of a toolbox of influenza PA-reporter viruses. (A) Schematic of
PA-reporter gene fusions encoding PA polyproteins containing the 2A peptide (PA-2A-GFP [PATG]
and PA-2A-RFP [PATR]) or PA direct fusions that lack the 2A sequence (PA-SWAP-NLuc [PASN]).
Silent mutations introduced into the terminal 47 nt of the PA coding sequence are depicted with
diagonal lines and the 50 nt repeat of the PA open reading frame (ORF) that maintains the packaging
signal is shown; (B,C) Multicycle replication kinetics of parental WSN and PA-reporter viruses in
A549 cells infected at a multiplicity of infection (MOI) = 0.01. Viral titers were determined at the
indicated time points by plaque assay. Data are mean of n = 3 ˘ standard deviation (sd). statistically
significant differences between WSN and the reporter viruses are marked (* p < 0.05, Student’s t-test).
2. Materials and Methods
2.1. Plasmids, Cells and Antibodies
The influenza reverse genetics system pTM-polI-WSN-All was a kind gift from Y. Kawaoka [16].
pTM∆RNP was derived from pTM-polI-WSN-All [17]. The virus rescue constructs pBD-PB1, -PB2,
-PA, and -NP express both viral RNA (vRNA) and messenger (mRNA) and have been described
previously [17,18].
PA-based reporter genes ere cted following our previous approach [1]. Briefly,
the PA open reading frame (ORF) was fused to coding sequence for Nluc, mRFP or eGFP. NLuc
sequences wer amplified from pNL1.1 (Pro , ison, WI, USA). To restore the required
packaging signal, the 31 50 nt from the PA ORF were repeated after the reporter genes and
followed by the untranslated region from the PA gene. Where indicated, the 31 50 nt in the PA
ORF were codon optimized (i.e., “swapped”) to remove duplicate packaging signals and sequence
repeats. Finally, certain reporter constructs also encoded the “self-cleaving” 2A peptide from porcine
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teschovirus, resulting in expression of a polyprotein that is processed following translation into
distinct polypeptides for PA and the reporter. Sequences for these reporter genes have been deposited
in GenBank (KT377269-KT377271). Western blots were performed with rabbit anti-PA antibodies
(kindly provided by G. Zvirblis [19]).
MDCK, MDBK, 293T and A549 cells were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum. All cells were grown at 37 ˝C in 5% CO2. Infections
were performed in media supplemented with 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 0.3% bovine serum albumin (BSA), 1X penicillin/ streptomycin, and 0.25 to 0.5 µg/mL
L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-trypsin.
2.2. Virus Production, Infections and Attachment Assay
Virus was recovered by reverse transfection of rescue plasmids into a co-culture containing 293T
and MDBK cells [1]. Viruses were subsequently amplified in MDBK cells or embryonated eggs, and
titers were determined by a plaque assay performed on MDCK cells. The genotype of reporter viruses
was confirmed by diagnostic reverse transcription polymerase chain reaction (RT-PCR).
Multicycle replications were initiated by infecting A549 cells at a multiplicity of infection (MOI)
of 0.01 in media supplemented with 25 mM HEPES, 0.3% (BSA), 1X penicillin/streptomycin, and
0.25 to 0.5 µg/mL TPCK-trypsin. Aliquots were removed at the indicated time points and titered by
a plaque assay to determine viral load. Viruses encoding fluorescent reporters were used to infect
A549 cells and were visualized by fluorescence microscopy at the peak of fluorescence (18–19 hours
post-infection (hpi)). Single-cycle infections to detect multiplicity reactivation were performed in
MDCK cells in a 96-well format. Cells were co-infected with PASTN at an MOI of 0.005 and the
indicated amount of the parental WSN. Viral gene expression was quantitated 8 hpi by performing a
Nano-Glo assay (Promega) [1].
Virion attachment assays were performed with PASN that was purified by centrifugation
through a 20% sucrose cushion. A549 or MDCK cells were seeded in a 96-well plate the day prior.
Where noted, cells were pre-treated with 5 µL/mL of receptor-destroying enzyme supplemented
with 100 µg/mL CaCl2 (Vibrio cholera filtrate, C8772, Sigma-Aldrich, St. Louis, MO, USA). Virions
were added to cells, incubated for the indicated amount of time, and unbound virions were removed
by washing. Bound virions were detected by performing a Nano-Glo assay (Promega) [1].
2.3. Mouse Infections and Imaging
Female BALB/c mice (Jackson Laboratory, Bar Harbor, ME, USA) (4 to 6 weeks old) were
inoculated intranasallywith 103 plaque-forming units (pfu) of PASTN in 25 µL under light isoflurane
anesthesia. Body weight was monitored daily. Mice losing >20% of their original body weight were
euthanized. Mice were treated with oseltamivir (BAM66450, Synchem, Elk Grove Village, IL, USA)
at 10 mg/kg twice daily via oral gavage, or mock treated, beginning two days post-infection
(dpi). Bioluminescent imaging and analyses were performed as described [1]. Positron emission
tomography–computed tomography (PET/CT) imaging was performed on an Inveon microPET/CT
using the radiotracer probe [18F]-2-deoxy-2-fluoro-D-glucose (18F-FDG). All animal studies were
reviewed and performed in accordance with the University of Wisconsin—Madison Institutional
Animal Care and Use Committee. Additionally, animal studies were conducted in accordance with
the GSK Policy on the Care, Welfare and Treatment of Laboratory Animals and were reviewed the
Institutional Animal Care and Use Committee at GSK.
3. Results and Discussion
We expanded the scope and utility of our reporter virus system by creating derivatives with the
fluorescent proteins enhanced green fluorescent protein (eGFP) (PA-2A-GFP [PATG]) and monomeric
red fluorescent protein (mRFP) (PA-2A-RFP [PATR]) (Figure 1A). Constructs were created following
our previously published approach that maintains the complete PA coding sequence and duplicates
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sequence to recreate the contiguous packaging signals necessary for virus production [1]. Reporter
constructs were also created that lacked the 2A peptide sequence, creating PA fusion proteins that
mediate the specific packaging of the NLuc reporter proteins into viral particles (PA-SWAP-NLuc
[PASN]). PA-based reporter viruses were rescued as described and incorporation of full-length
reporter genes was verified by RT-PCR of viral stocks [1,17,20]. Silent mutations were introduced
into the packaging signals contained within the PA ORF of most constructs on the premise that it
would enhance genome stability [1]. However, these changes were not essential as both eGFP and
mRFP were retained in their respective viruses without silent mutations in the packaging sequence.
Replication kinetics of the multi-label reporter virus system were characterized in human A549
lung cells (Figure 1B,C). Replication of PASN, which encodes the PA-NLuc fusion, was nearly
indistinguishable from WSN. Despite the relatively large size of mRFP, PATR replicated similar to
WSN, although the peak viral titer of PATR was slightly reduced compared to the parental virus. The
GFP reporter virus PATG exhibited the highest degree of attenuation, and replicated similar to some
other existing reporter viruses with titers >1 log below WSN. Similar to what was seen for PASTN [1],
plaques for these reporter viruses were smaller and less sharply defined when compared to parental
WSN. As different reporter viruses replicate with different properties, care must be taken when
combining reporters in the same experiment. Perhaps unexpectedly, there was no clear correlation
between native replicative capacity of the reporter virus and the size of the reporter, its fusion to PA,
or if silent mutations were present in PA.
Reporter viruses were used to study early stages in the viral life cycle, beginning with attachment
using bioluminescent PASN virions. Hemagglutinin (HA)-mediated attachment to sialic acids on
the cell surface is essential during infection and is often disrupted by HA-specific antibodies [21].
Western blotting of PA from infected cells showed that all of the reporter viruses expressed PA at
similar level, regardless of the nature of the reporter protein or whether it remained fused to PA
(Figure 2A). Blotting of purified virions showed that direct fusion of NLuc to PA resulted in specific
packaging of PA-NLuc into PASN virions creating bioluminescent particles, but not the polyprotein
of PASTN virions (Figure 2A). To measure the kinetics of virion binding in a high-throughput setting,
PASN was incubated with A549 or MDCK cells in a 96-well format (Figure 2B). In parallel, assays
were performed on cells pre-treated with neuraminidase to remove sialic acids. At the indicated
times, free virions were removed by washing and bound virions were detected by performing a
NanoGlo luciferase assay. As the NLuc reporter is packaged within the virion, these assay are
designed to measure virion binding to cells, and not infection per se. Binding to A549 and MDCK cells
proceeded rapidly and reached a maxima in ~45 min, paralleling prior analyses [22]. Furthermore,
neuraminidase treatment reduced binding to background levels indicating that virion binding, and
resultant luciferase activity, required sialic acids on the cell surface. To determine the sensitivity of the
binding assay, we repeated the experiments with decreasing amounts of virions and allowed binding
to proceed to completion (Figure 2C). Our data show a strong linear relationship over 4 logs between
input and bound virions. Binding by as few as 100 pfu yielded a reproducible and statistically
significant signal above background. This is a highly sensitive readout considering that this assay
directly measures virion binding, and does not benefit from the signal amplification that occurs when
infections are allowed to proceed to viral gene expression or replication. The entire binding assay
was completed in under an hour, demonstrating that bioluminescent PASN particles can be used for
the rapid and specific measurement of virion attachment without the need for virus replication. This
assay could be easily adapted to measure receptor binding specificity or the ability of neutralizing
antibodies or similar therapeutics to block attachment.
Following attachment and entry, fluorescent reporter viruses are especially useful in tracking
gene expression at the cellular level without the administration of exogenous substrate for reporter
activity. Live-cell microscopy detected robust fluorescence in A549 cells infected with PATG and
PATR, but not WSN (Figure 3A). Singly infected and co-infected cells were simultaneously detected
in cultures exposed to both PATG and PATR.
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Whereas many assays, such as plaque assays and the determination of the 50% Tissue Culture
Infective Dose (TCID50), rely on successful infection and completion of the viral life cycle, our
fluorescent and bioluminescent viruses report on gene expression, and not necessarily the capacity
to produce infectious particles. It has recently been suggested that a large percentage of influenza
virions are capable of initiating infections, but cannot support production of infectious progeny,
so-called “semi-infectious” virions [23]. As such, these semi-infectious virions are not detected in
viral titer measurements that rely on multiple rounds of infection, including the plaque assays used
here to titer our viral stocks. We exploited the fact that PATG reports on viral gene expression to
test for the presence of semi-infectious particles during early stages of infection (Figure 3B). Cells
were infected with increasing amounts of virus and imaged to detect total cells (Hoechst 33342) and
those expressing a virally encoded gene (GFP). These experiments routinely detected 3–5 fold more
cells expressing virally encoded GFP than would be predicted based on the MOI used to initiate
the infection; all of the cells inoculated at an MOI = 0.4 were GFP-positive, when only ~33% are
predicted to be infected assuming an ideal Poisson distribution (Figure 3B). This disconnect between
MOIs based on pfu and the number of GFP-positive cells in the resultant infection suggests that our
reporters detect a large number of semi-infectious events that initiate infections and gene expression,
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PASN  packages  PA‐NLuc  fusions  to  create  bioluminescent  virions.  (A)  PA  fusion  proteins were 
detected by western blotting of  lysates  from  infected cells  (left) or virions purified  through a 20% 
sucrose  cushion  (right);  (B) PASN  attachment assay. 106 plaque‐forming units  (pfu) of PASN per 









Multiplicity  reactivation  predicts  that  semi‐infectious  events  can  be  complemented  during  
co‐infection to restore viral gene expression and potentially virus production [24]. To address this 
possibility quantitatively and provide  further  support  for  the  largely qualitative  results obtained 
Figure 2. Bioluminescent virions provide a rapid and quantitative measure of attachment to cells.
PASN packages PA-NLuc fusions to create bioluminescent virions. (A) PA fusion proteins were
detected by western blotting of lysates from infected cells (left) or virions purified through a 20%
sucrose cushion (right); (B) PASN attachment assay. 106 plaque-forming units (pfu) of PASN per well
were incubated with A549 or MDCK cells at 37 ˝C for the indicated time. Where noted, cells were
pre-treated with receptor destroying enzyme (RDE) to remove sialic acids. Following washing to
remove unbound virus, attached virions were measured in a 96-well NanoGlo assay. Data are mean
of n = 3 ˘ sd; (C) A highly sensitive attachment assay. A549 or MDCK cells were incubated with
dilutions of virus at 4 ˝C for 45 min to allow binding to go to completion. Following washing to
remove unbound virus, attached virions were measured in a 96-well NanoGlo assay and the limit of
detection was set to background luminescence in the absence of infection. Data are mean of n = 4 ˘ sd.
Statistically significant differences between cells inoculated with PASN or media alone for each cell
line are marked (* p < 0.001, Student’s t-test).
Multiplicity reactivation predicts that semi-infectious events can be complemented during
co-infection to restore viral gene expression and potentially virus production [24]. To address this
possibility quantitatively and provide further support for the largely qualitative results obtained
with PATG, cells were co-infected with PASTN and non-reporter WSN in an attempt to restore
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NLuc expression from semi-infectious reporter viruses. Single-cycle infections were initiated with
a very low MOI of PASTN (0.005) in the presence of increasing amounts of the non-reporter WSN
(Figure 3C). Addition of WSN increased expression of PASTN-encoded NLuc upwards of 3-fold,
suggesting either co-infection by fully infectious particles or complementation of defective PASTN
by the parental WSN. Strikingly, complementation still occurred when both viruses were present
at an MOI of 0.005, conditions where co-infection by fully infectious particles is highly unlikely
(i.e., using viral titers determined by plaque assays to establish the inoculum, less than 1 cell out of
the 25,000 total per well is predicted to be co-infected by fully infectious particles when both viruses
are at an MOI of 0.005). This suggests that some of the enhanced gene expression for PASTN resulted
from complementation during co-infection by two “semi-infectious” particles. Moreover, as WSN
enhanced NLuc expression which was only present in the reporter virus genome, these data provide
evidence that one mode of multiplicity reactivation occurs by restoring expression from an otherwise
inactive gene segment, as opposed to solely supplying a replacement for the defective segment. By
exploiting the unique advantages of these reporter viruses, we have established methods to quantitate
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with  PATG,  PATR, WSN  or  co‐infected with  PATG  and  PATR.  Infected  cells were  detected  by 
fluorescence  microscopy  18–19  hours  post‐infection  (hpi)  and  cells  were  counter‐stained  with 
Hoechst  33342  to detect nuclei. Co‐infection  is  indicated by  the  arrowheads;  (B) A549  cells were 
infected with an  increasing MOI of PATG. Cells were  imaged  to detect  total cells  (Hoechst 33342) 
and those expressing a virally encoded gene (GFP). All of the cells are GFP‐positive when only an 
MOI  =  0.4  is  used;  (C) Multiplicity  reactivation  rescues  viral  gene  expression. A  total  of  25,000 
MDCK cells were infected in a 96‐well format with PASTN at an MOI = 0.005. Where indicated, cells 
were also simultaneously infected with increasing amounts of WSN. A luciferase activity assay was 
performed 10 hpi  to determine PASTN gene expression  for each  condition  (average  relative  light 
units (RLU), Data are mean of n = 4 ± sd). Conditions with a statistically significant increase in gene 
expression compared to PASTN alone are marked (* p < 0.05, Student’s t‐test). 
A  key  advantage  of  using  non‐invasive  reporters  is  the  capacity  for  longitudinal measures 
throughout  the course of  infection and sequential measures using different  imaging modalities or 
spectra.  Using  longitudinal  bioluminescent  imaging  to  measure  virus  replication  and  tissue 
distribution in the same animals, we evaluated the antiviral kinetics of the neuraminidase inhibitor 
oseltamivir (OSV). Animals were  treated beginning 2 days post PASTN  inoculated and viral  load 
was quantified by in vivo  imaging  (Figure 4A).  In contrast  to untreated animals, virus  replication 
Figure 3. Influenza reporter viruses detect infection, co-infection, “se i-infection” and ultiplicity
reactivation. ive cell i aging of viral gene ex ression in infecte cells. ( ) 549 cells ere infecte
it , T , r c -i fecte it a TR. I fecte cells ere etecte
fl r sc c microscopy 18–19 hours post-infection (hpi) and cells w re count r-stai d with Hoechst
33342 to detect nuclei. Co-infecti n is indicated by th arrowheads; (B) A549 cells were infected
with an increasing MOI of PATG. Cells were imaged to detect total cells (Hoechst 33342) and those
expressing a virally encoded g e (GFP). All of the ce s are GFP-positive when only an MOI = 0.4
is used; (C) Multiplicity reactivation rescues viral gene exp essio . A total of 25,000 MDCK cells
were inf cted in a 96-w ll format ith PASTN a an MOI = 0.005. Where indicat d, cells w re also
simultaneously infected w th increas ng amounts of WSN. A luciferase activity ass y was performed
10 hpi to determine PASTN gene expressio for each condition (average relati e li ht uni s (RLU),
Data are mean of n = 4 ˘ sd). Conditions with a statistically signifi nt increase in gen expression
compared to PASTN al ne are m rked (* p < 0.05, Student’s t-test).
A key advantage of using non-invasive reporters is the capacity for longitudinal easures
throughout the course of infection and sequential measures using different imaging modalities
or spectra. Using longitudinal bioluminescent imaging to measure virus replication and tissue
distribution in the sa e ani als, e evaluated the antiviral kinetics of the neura inidase inhibitor
oselta ivir (OSV). Ani als ere treated beginning 2 days post PAST inoculated and viral load
as quantified by in vivo imaging (Figure 4A). In contrast to untreated animals, virus replication was
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significantly reduced with OSV treatment (p = 0.0085, 2-way ANOVA) and was below the limit of
detection by 7 days post infection (dpi), preventing an otherwise lethal infection.
We then paired bioluminescence and PET/CT imaging to measure both virus replication
and inflammation. Inflammation was measured in a subset of mice at 5 dpi using 18F-FDG, a
radiotracer for detecting influenza-mediated inflammation [25] (Figure 4B). Lungs were segmented
from computed tomography (CT) data using three Hounsfield unit thresholds to prevent artifacts
due to changes in lung tissue density from edema and immune infiltrates. Inflammation was then
measured from the positron emission tomography (PET) data by quantifying 18F-FDG localized to
each of the CT-defined lung volumes (Figure 4C). OSV treatment dramatically reduced inflammation
compared to mock-treated animals, approaching background levels detected in an uninfected control.
Multi-modal imaging enabled measurement of both viral replication and host responses, and showed
a remarkable correlation between viral load and inflammation in mice.
In conclusion, we report the generation of a versatile toolbox of influenza A reporter viruses.
These viruses are suited for probing discrete stages of the viral replication cycle at the cellular
level—from attachment to the cell, through gene expression, and ultimately the spread of released
virus. Moreover, multi-modal in vivo imaging experiments demonstrate the ability to simultaneously
measure viral replication, the efficacy of antiviral or immunomodulatory therapy, the host antiviral
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Figure  4. Multi‐modal  imaging  of  the  effect  of  antiviral  treatment  on  influenza  virus‐mediated 
inflammation.  (A)  Infected mice were  treated with  oseltamivir  (OSV,  10 mg/kg  bid)  beginning  2 
days post  infection  (dpi)  or mock  treated;  Serial  bioluminescence  imaging  of  the  same  cohort  of 
animals was used to detect statistically significant differences in viral load over time between mock 
and OSV  treatment  (p  =  0.0085,  2‐way ANOVA);  (B) Multi‐modal  bioluminescence  and  positron 
emission  tomography–computed  tomography  (PET/CT)  imaging.  [18F]‐2‐deoxy‐2‐fluoro‐D‐glucose 
(18F‐FDG) was  used  as  a  probe  to measure  inflammation  in  the  lungs. Representative data  from 
uninfected  and  infected  mice  are  shown;  (C)  Dual  quantification  of  viral  load  (bioluminescent 
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